May 24 (Reuters) - Bristol-myers Squibb Co BMY.N
* Myers squibb announces health canada's approval of
daklinza in combination with sofosbuvir
* Says health canada's approval of daklinza in treatment of
chronic hepatitis c in adult patients
Source text for Eikon: ID:nCNWvYX82a
Further company coverage: BMY.N
(Bengaluru Newsroom: +1-646-223-8780)